COMPARISON OF LONG-TERM OUTCOMES AFTER CONVERSION TO BELATACEPT WITH EITHER TACROLIMUS (TAC) OR MYCOPHENOLATE (MMF) AND PREDNISONE. Issue 3 (September 2020)